Kg Biopharma Consulting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced the appointment of Ms. Kathryn Gregory as Vice President and Head of Corporate Business Development, reporting to Mr. John F. Chin, Chief Business Officer of Antengene. In this role, Kathryn will be responsible for leading external business development including in/out-licensing, co-development/commercialization, mergers and acquisitions, and other collaboration agreements supporting Antengene's objectives. ....

United States , Johnf Chin , Jay Mei , Kathryn Gregory , Asia Pacific , Seneb Biosciences , Kg Biopharma Consulting , University Of California , Antengene Corporation , Calithera Biosciences Inc , Antengene Corporation Limited , Pepperdine University , Chief Business Officer , Calithera Biosciences , New Drug Applications , Corporation Limited , Asia Pacific Region , Patients Beyond , Antengene Corporation Limited , Chief Business Officer , Biopharmaceutical Industry , Business Development , Johnf Chin , Leadership Experience , Operational Experience , ஒன்றுபட்டது மாநிலங்களில் ,